Concurrent Investment Advisors’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Concurrent Investment Advisors’s Portfolio IBBQ Stock Details IBBQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$426K	Buy	+14,701	New	+$428K	﹤0.01%	1296

Other funds holding IBBQ

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

WMS Group Folsom, Louisiana $68.8M AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

KAM

Knightsbridge Asset Management Newport Beach, California $743M AUM 28.33% 1-Year Est. Return

IAA

Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return

Concurrent Investment Advisors's IBBQ Position: Q1 2026 in Review

Concurrent Investment Advisors opened a new position in Invesco NASDAQ Biotechnology ETF (IBBQ) in Q1 2026: 14,701 shares worth $426K. The stake represents ﹤0.01% of the portfolio and ranks #1296 among its holdings.

39 funds tracked by Wall St. Rank hold IBBQ as of Q1 2026.

Concurrent Investment Advisors held 14,701 shares of Invesco NASDAQ Biotechnology ETF worth $426K as of Q1 2026.
Invesco NASDAQ Biotechnology ETF was a new Concurrent Investment Advisors position in Q1 2026.
Invesco NASDAQ Biotechnology ETF made up ﹤0.01% of Concurrent Investment Advisors's portfolio in Q1 2026, its #1296 holding.
39 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q1 2026.

Based on Concurrent Investment Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.